Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer

Zheng Chen, Tianling Hu, Shoumin Zhu, Kenichi Mukaisho, Wael El-Rifai, Dunfa Peng

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Gastric cancer (GC) is one of the most common cancers in the world, and remains the third leading cause of cancer-related deaths worldwide. Glutathione peroxidase 7 (GPX7) is a member of GPX family which is downregulated in some cancer types. In this study, we investigated the expression, regulation, and molecular function of GPX7 in gastric cancer using 2D and 3D in vitro models and de-identified human tissue samples. Quantitative real-time RT-PCR, immunofluorescence, Western blot, 3D organotypic cultures, and pyrosequencing assays were used. We detected downregulation of GPX7 in all 7 gastric cancer cell lines that we tested and in approximately half (22/45) of human gastric cancer samples, as compared to histologically normal gastric tissues. Quantitative bisulfite pyrosequencing methylation analysis demonstrated DNA hypermethylation (> 10% methylation level) of GPX7 promoter in all 7 gastric cancer cell lines and in 56% (25/45) of gastric cancer samples, as compared to only 13% (6/45) in normal samples (p < 0.0001). Treatment of AGS and SNU1 cells with 5-Aza-2'-deoxycytidine led to a significant demethylation of GPX7 promoter and restored the expression of GPX7. In vitro assays showed that reconstitution of GPX7 significantly suppressed gastric cancer cell growth in both 2D and 3D organotypic cell culture models. This growth suppression was associated with inhibition of cell proliferation and induction of cell death. We detected significant upregulation of p27 and cleaved PARP and downregulation of Cyclin D1 upon reconstitution of GPX7. Taken together, we conclude that epigenetic silencing of GPX7 could play an important role in gastric tumorigenesis and progression.

Original languageEnglish (US)
Pages (from-to)54345-54356
Number of pages12
JournalOncotarget
Volume8
Issue number33
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Glutathione Peroxidase
Stomach Neoplasms
Growth
Neoplasms
Down-Regulation
decitabine
Methylation
Stomach
Cell Line
Cyclin D1
Epigenomics
Fluorescent Antibody Technique
Real-Time Polymerase Chain Reaction
Carcinogenesis
Cell Death
Up-Regulation
Cell Culture Techniques
Western Blotting
Cell Proliferation
DNA

Keywords

  • Cancer
  • DNA methylation
  • GPX7
  • Stomach
  • Tumor suppressor

ASJC Scopus subject areas

  • Oncology

Cite this

Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer. / Chen, Zheng; Hu, Tianling; Zhu, Shoumin; Mukaisho, Kenichi; El-Rifai, Wael; Peng, Dunfa.

In: Oncotarget, Vol. 8, No. 33, 01.01.2017, p. 54345-54356.

Research output: Contribution to journalArticle

Chen, Zheng ; Hu, Tianling ; Zhu, Shoumin ; Mukaisho, Kenichi ; El-Rifai, Wael ; Peng, Dunfa. / Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer. In: Oncotarget. 2017 ; Vol. 8, No. 33. pp. 54345-54356.
@article{bd8bc60352734b8ba557cafc1542acdd,
title = "Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer",
abstract = "Gastric cancer (GC) is one of the most common cancers in the world, and remains the third leading cause of cancer-related deaths worldwide. Glutathione peroxidase 7 (GPX7) is a member of GPX family which is downregulated in some cancer types. In this study, we investigated the expression, regulation, and molecular function of GPX7 in gastric cancer using 2D and 3D in vitro models and de-identified human tissue samples. Quantitative real-time RT-PCR, immunofluorescence, Western blot, 3D organotypic cultures, and pyrosequencing assays were used. We detected downregulation of GPX7 in all 7 gastric cancer cell lines that we tested and in approximately half (22/45) of human gastric cancer samples, as compared to histologically normal gastric tissues. Quantitative bisulfite pyrosequencing methylation analysis demonstrated DNA hypermethylation (> 10{\%} methylation level) of GPX7 promoter in all 7 gastric cancer cell lines and in 56{\%} (25/45) of gastric cancer samples, as compared to only 13{\%} (6/45) in normal samples (p < 0.0001). Treatment of AGS and SNU1 cells with 5-Aza-2'-deoxycytidine led to a significant demethylation of GPX7 promoter and restored the expression of GPX7. In vitro assays showed that reconstitution of GPX7 significantly suppressed gastric cancer cell growth in both 2D and 3D organotypic cell culture models. This growth suppression was associated with inhibition of cell proliferation and induction of cell death. We detected significant upregulation of p27 and cleaved PARP and downregulation of Cyclin D1 upon reconstitution of GPX7. Taken together, we conclude that epigenetic silencing of GPX7 could play an important role in gastric tumorigenesis and progression.",
keywords = "Cancer, DNA methylation, GPX7, Stomach, Tumor suppressor",
author = "Zheng Chen and Tianling Hu and Shoumin Zhu and Kenichi Mukaisho and Wael El-Rifai and Dunfa Peng",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.17527",
language = "English (US)",
volume = "8",
pages = "54345--54356",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "33",

}

TY - JOUR

T1 - Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer

AU - Chen, Zheng

AU - Hu, Tianling

AU - Zhu, Shoumin

AU - Mukaisho, Kenichi

AU - El-Rifai, Wael

AU - Peng, Dunfa

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Gastric cancer (GC) is one of the most common cancers in the world, and remains the third leading cause of cancer-related deaths worldwide. Glutathione peroxidase 7 (GPX7) is a member of GPX family which is downregulated in some cancer types. In this study, we investigated the expression, regulation, and molecular function of GPX7 in gastric cancer using 2D and 3D in vitro models and de-identified human tissue samples. Quantitative real-time RT-PCR, immunofluorescence, Western blot, 3D organotypic cultures, and pyrosequencing assays were used. We detected downregulation of GPX7 in all 7 gastric cancer cell lines that we tested and in approximately half (22/45) of human gastric cancer samples, as compared to histologically normal gastric tissues. Quantitative bisulfite pyrosequencing methylation analysis demonstrated DNA hypermethylation (> 10% methylation level) of GPX7 promoter in all 7 gastric cancer cell lines and in 56% (25/45) of gastric cancer samples, as compared to only 13% (6/45) in normal samples (p < 0.0001). Treatment of AGS and SNU1 cells with 5-Aza-2'-deoxycytidine led to a significant demethylation of GPX7 promoter and restored the expression of GPX7. In vitro assays showed that reconstitution of GPX7 significantly suppressed gastric cancer cell growth in both 2D and 3D organotypic cell culture models. This growth suppression was associated with inhibition of cell proliferation and induction of cell death. We detected significant upregulation of p27 and cleaved PARP and downregulation of Cyclin D1 upon reconstitution of GPX7. Taken together, we conclude that epigenetic silencing of GPX7 could play an important role in gastric tumorigenesis and progression.

AB - Gastric cancer (GC) is one of the most common cancers in the world, and remains the third leading cause of cancer-related deaths worldwide. Glutathione peroxidase 7 (GPX7) is a member of GPX family which is downregulated in some cancer types. In this study, we investigated the expression, regulation, and molecular function of GPX7 in gastric cancer using 2D and 3D in vitro models and de-identified human tissue samples. Quantitative real-time RT-PCR, immunofluorescence, Western blot, 3D organotypic cultures, and pyrosequencing assays were used. We detected downregulation of GPX7 in all 7 gastric cancer cell lines that we tested and in approximately half (22/45) of human gastric cancer samples, as compared to histologically normal gastric tissues. Quantitative bisulfite pyrosequencing methylation analysis demonstrated DNA hypermethylation (> 10% methylation level) of GPX7 promoter in all 7 gastric cancer cell lines and in 56% (25/45) of gastric cancer samples, as compared to only 13% (6/45) in normal samples (p < 0.0001). Treatment of AGS and SNU1 cells with 5-Aza-2'-deoxycytidine led to a significant demethylation of GPX7 promoter and restored the expression of GPX7. In vitro assays showed that reconstitution of GPX7 significantly suppressed gastric cancer cell growth in both 2D and 3D organotypic cell culture models. This growth suppression was associated with inhibition of cell proliferation and induction of cell death. We detected significant upregulation of p27 and cleaved PARP and downregulation of Cyclin D1 upon reconstitution of GPX7. Taken together, we conclude that epigenetic silencing of GPX7 could play an important role in gastric tumorigenesis and progression.

KW - Cancer

KW - DNA methylation

KW - GPX7

KW - Stomach

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=85029062305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029062305&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.17527

DO - 10.18632/oncotarget.17527

M3 - Article

AN - SCOPUS:85029062305

VL - 8

SP - 54345

EP - 54356

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 33

ER -